Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
388 studies found for:    "Myelodysplastic/myeloproliferative disease"
Show Display Options
Rank Status Study
1 Recruiting Italian Network MDS Registry
Condition: Myelodysplastic-Myeloproliferative Diseases
Intervention:
2 Recruiting A Phase 1 Study Evaluating CPI-0610 in Patients With Acute Leukemia, Myelodysplastic Syndrome, Myelodysplastic/Myeloproliferative Neoplasms, and Myelofibrosis
Conditions: Leukemia, Myelocytic, Acute;   Myelodysplastic Syndrome (MDS);   Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable;   Myelofibrosis
Intervention: Drug: CPI-0610
3 Completed Combination Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorders
Conditions: Chronic Myeloproliferative Disorders;   Leukemia;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Drug: busulfan;   Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: methotrexate;   Drug: tacrolimus;   Procedure: allogeneic bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation
4 Terminated Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia
Conditions: Chronic Myeloproliferative Disorders;   Leukemia;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Drug: cyclophosphamide;   Drug: cyclosporine;   Drug: fludarabine phosphate;   Drug: methylprednisolone;   Drug: therapeutic allogeneic lymphocytes;   Drug: thiotepa;   Procedure: allogeneic bone marrow transplantation;   Procedure: biological therapy;   Procedure: bone marrow ablation with stem cell support;   Procedure: bone marrow transplantation;   Procedure: chemotherapy;   Procedure: leukocyte therapy;   Procedure: non-specific immune-modulator therapy;   Procedure: peripheral blood lymphocyte therapy;   Procedure: peripheral blood stem cell transplantation;   Procedure: radiation therapy
5 Unknown  Tipifarnib in Treating Patients With Myeloproliferative Disorders
Conditions: Leukemia;   Myelodysplastic/Myeloproliferative Neoplasms
Intervention: Drug: tipifarnib
6 Completed Anti-Thymocyte Globulin and Etanercept in Treating Patients With Myelodysplastic Syndromes
Conditions: Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Biological: anti-thymocyte globulin;   Biological: etanercept
7 Unknown  Donor Stem Cell Transplant With or Without Chemotherapy in Treating Children With Primary Myelodysplastic Syndrome
Conditions: Leukemia;   Myelodysplastic/Myeloproliferative Neoplasms
Interventions: Drug: cytarabine;   Drug: mercaptopurine;   Other: laboratory biomarker analysis;   Procedure: allogeneic bone marrow transplantation;   Procedure: biopsy;   Procedure: peripheral blood stem cell transplantation
8 Completed Amifostine in Treating Young Patients With Newly Diagnosed De Novo Myelodysplastic Syndromes
Conditions: Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms
Intervention: Drug: amifostine trihydrate
9 Completed Clofarabine and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia, or Myeloproliferative Disorders
Conditions: Chronic Myeloproliferative Disorders;   Leukemia;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Drug: clofarabine;   Drug: cyclophosphamide
10 Completed Pilot Study Of Unrelated UCB Transplant for Non-Malignant Hematologic Conditions
Conditions: Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Biological: anti-thymocyte globulin;   Drug: busulfan;   Drug: cyclophosphamide;   Drug: melphalan;   Drug: methylprednisolone;   Procedure: bone marrow ablation with stem cell support;   Procedure: umbilical cord blood transplantation;   Radiation: radiation therapy
11 Completed Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer
Conditions: Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Biological: anti-thymocyte globulin;   Biological: filgrastim;   Biological: sargramostim;   Biological: therapeutic immune globulin;   Drug: cyclophosphamide;   Drug: methotrexate;   Drug: tacrolimus;   Procedure: allogeneic bone marrow transplantation;   Radiation: radiation therapy
12 Completed Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes
Conditions: Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Biological: etanercept;   Drug: arsenic trioxide
13 Completed 3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic Syndrome
Conditions: Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Drug: fludarabine phosphate;   Drug: triapine
14 Completed Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome
Conditions: Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Intervention: Biological: sargramostim
15 Completed Doxercalciferol in Treating Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
Conditions: Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Intervention: Dietary Supplement: doxercalciferol
16 Completed
Has Results
Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201)
Conditions: Leukemia;   Myeloproliferative Disorders;   Myelodysplastic-Myeloproliferative Diseases
Interventions: Biological: Allogeneic bone marrow transplantation;   Biological: Peripheral blood stem cell transplantation
17 Active, not recruiting Bexarotene and GM-CSF in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
Conditions: Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Biological: sargramostim;   Drug: bexarotene;   Genetic: cytogenetic analysis;   Genetic: fluorescence in situ hybridization;   Other: flow cytometry;   Other: laboratory biomarker analysis;   Procedure: biopsy
18 Completed Fludarabine/Carboplatin/Topotecan w/Thalidomide for Relapsed/Refractory AML, CML and MDS
Conditions: Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Drug: carboplatin;   Drug: fludarabine phosphate;   Drug: thalidomide;   Drug: topotecan hydrochloride
19 Completed Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer
Conditions: Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Drug: sodium phenylbutyrate;   Drug: tretinoin
20 Completed Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
Conditions: Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Biological: filgrastim;   Drug: busulfan;   Drug: etoposide;   Procedure: autologous bone marrow transplantation

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.